Parsippany, NJ, United States of America

Tobira Therapeutics, Inc.


USPTO Granted Patents = 8

% Expired Patents = 50.0



Forward Citations = 15

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Masanori Baba (4 out of 37 patents)

silverMedal Masaki Seto (4 out of 50 patents)

bronzeMedal Katsuji Aikawa (4 out of 6 patents)

4.  Mitsuru Shiraishi (4 out of 43 patents)

5.  Naoyuki Kanzaki (4 out of 32 patents)

6.  Yuji Iizawa (4 out of 9 patents)

7.  Nicholas Morra (2 out of 2 patents)

8.  Pasit Phiasivongsa (2 out of 2 patents)

9.  Emma Sharp (1 out of 11 patents)

10.  Mark Michael Menning (1 out of 14 patents)

11.  Martin Ian Cooper (1 out of 10 patents)

12.  Sean Dalziel (1 out of 30 patents)

13.  Douglas Brooks (6 patents)

14.  Christopher P Rusconi (26 patents)

15.  Eric Lefebvre (0 patent)


8 patents:

Company Overview
Tobira Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for liver and infectious diseases. They are dedicated to improving the lives of patients through cutting-edge research and development efforts. With a strong pipeline of potential treatments, Tobira Therapeutics is committed to making a positive impact on healthcare worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#42 in Parsippany, NJ

#1,343 in New Jersey

#35,941 in US

Parsippany, NJ (US)
Parsippany, NJ, United States of America
Forward Citations = 15

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tobira Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tobira-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…